Pubertal development in daughters of women with pre-eclampsia

Archives of Disease in Childhood

Volumn 96, Issue 8, 2011, Pages 740-743

  Ogland, Bjorn ^a,b   Nilsen, Stein T ^a   Forman, Michele R ^c   Vatten, Lars J ^a,b  

^a STAVANGER UNIVERSITY HOSPITAL   (Norway)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN;

ADOLESCENT; ARTICLE; BREAST DEVELOPMENT; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; HUMAN EXPERIMENT; PREECLAMPSIA; PRIORITY JOURNAL; PUBERTY; SCORING SYSTEM; SELF EVALUATION; TANNER SCORE;

ADOLESCENT; ADOLESCENT DEVELOPMENT; BREAST; CASE-CONTROL STUDIES; CHILD; FEMALE; FOLLOW-UP STUDIES; HAIR; HUMANS; PRE-ECLAMPSIA; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PUBERTY;

EID: 79960556538     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2009.178434     Document Type: Article

References (16)

1. Roberts JM, Cooper DW. Pathogenesis and genetics of pre-eclampsia. Lancet 2001;357:53-6. (Pubitemid 32056505)
2. Vatten LJ, Forman MR, Nilsen TI, et al. The negative association between preeclampsia and breast cancer risk may depend on the offspring's gender. Br J Cancer 2007;96:1436-8. (Pubitemid 46685775)
3. Forman MR, Cantwell MM, Ronckers C, et al. Through the looking glass at early-life exposures and breast cancer risk. Cancer Invest 2005;23:609-24. (Pubitemid 43286663)
4. Ekbom A, Hsieh CC, Lipworth L, et al. Intrauterine environment and breast cancer risk in women: a population-based study. J Natl Cancer Inst 1997;89:71-6. (Pubitemid 26428080)
5. Troisi R, Potischman N, Hoover RN. Exploring the underlying hormonal mechanisms of prenatal risk factors for breast cancer: a review and commentary. Cancer Epidemiol Biomarkers Prev 2007;16:1700-12. (Pubitemid 47450497)
6. Kelsey J. Breast cancer epidemiology: summary and future direct]ions. Epidemiol Rev 1993;15:256-63.
7. Rosenfield A. Puberty in the female and its disorders. In: Sperling MA, ed. Pediatric Endocrinology. Philadelphia, PA: WB Saunders 2002:455-518.
8. Marshall WA, Tanner JM. Variations in pattern of pubertal changes in girls. Arch Dis Child 1969;44:291-303.
9. Biro FM, Lucky AW, Simbartl LA, et al. Pubertal maturation in girls and the relationship to anthropometric changes: pathways through puberty. J Pediatr 2003;142:643-6. (Pubitemid 36737167)
10. Vatten LJ, Nilsen ST, Odegård RA, et al. Insulin-like growth factor I and leptin in umbilical cord plasma and infant birth size at term. Pediatrics 2002;109:1131-5. (Pubitemid 34587442)
11. CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group. Lancet 1994;343:619-29.
12. Marsál K, Persson PH, Larsen T, et al. Intrauterine growth curves based on ultrasonically estimated foetal weights. Acta Paediatr 1996;85:843-8. (Pubitemid 26267023)
13. Ibáñez L, de Zegher F. Puberty after prenatal growth restraint. Horm Res 2006;65(Suppl 3):112-15. (Pubitemid 44689442)
14. Neville KA, Walker JL. Precocious pubarche is associated with SGA, prematurity, weight gain, and obesity. Arch Dis Child 2005;90:258-61. (Pubitemid 40342387)
15. Ibáñez L, Díaz R, López-Bermejo A, et al. Clinical spectrum of premature pubarche: links to metabolic syndrome and ovarian hyperandrogenism. Rev Endocr Metab Disord 2009;10:63-76.
16. Ibáñez L, Potau N, Marcos MV, et al. Adrenal hyperandrogenism in adolescent girls with a history of low birthweight and precocious pubarche. Clin Endocrinol (Oxf) 2000;53:523-7.